Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study

被引:1
|
作者
Savulescu, Camelia [1 ]
Krizova, Pavla [2 ]
Lepoutre, Agnes [3 ]
Mereckiene, Jolita [4 ]
Vestrheim, Didrik F. [5 ]
Ciruela, Pilar [6 ,9 ]
Ordobas, Maria [7 ]
Guevara, Marcela [8 ,9 ]
McDonald, Eisin [10 ]
Morfeldt, Eva [11 ]
Kozakova, Jana [2 ]
Varon, Emmanuelle [12 ]
Cotter, Suzanne [4 ]
Winje, Brita A. [5 ]
Munoz-Almagro, Carmen [9 ,13 ,14 ]
Garcia, Luis [7 ]
Castilla, Jesus [8 ,9 ]
Smith, Andrew [15 ]
Henriques-Normark, Birgitta [11 ,16 ,17 ]
Celentano, Lucia Pastore [18 ]
Hanquet, Germaine [1 ]
机构
[1] EpiConcept, Epidemiol Dept, 47 Rue Charenton, F-75012 Paris, France
[2] Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Prague, Czech Republic
[3] French Natl Agcy Publ Hlth, Infect Dis Dept, St Maurice, France
[4] Hlth Protect Surveillance Ctr, Vaccine Preventable Dis Dept, Dublin, Ireland
[5] Norwegian Inst Publ Hlth, Dept Vaccine Preventable Dis, Oslo, Norway
[6] Publ Hlth Agcy Catalunya, Gen Sub Directorate Surveillance & Publ Hlth Emer, Barcelona, Spain
[7] Sub Directorate Hlth Promot & Prevent, Madrid, Spain
[8] Publ Hlth Inst Navarra IdiSNA, Pamplona, Spain
[9] CIBER Epidemiol & Salud Publ, Madrid, Spain
[10] Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland
[11] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden
[12] European Hosp George Pompidou, Natl Ctr Pneumococci, Paris, France
[13] Hosp San Juan Dios, Mol Microbiol Dept, Barcelona, Spain
[14] Univ Int Catalunya, Barcelona, Spain
[15] Meningococcus & Pneumococcus Reference Lab, Legionella, Scottish Haemophilus, Glasgow, Lanark, Scotland
[16] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden
[17] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden
[18] European Ctr Dis Prevent & Control, Off Chief Sci Unit, Stockholm, Sweden
来源
LANCET RESPIRATORY MEDICINE | 2017年 / 5卷 / 08期
关键词
SEROTYPE REPLACEMENT; IMPACT; VACCINATION; SURVEILLANCE; 7-VALENT; ENGLAND; COHORT; QUEBEC; CANADA; ADULTS;
D O I
10.1016/S2213-2600(17)30110-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors populations in nine sites in seven European countries for invasive pneumococcal disease. Five sites use 13-valent pneumococcal conjugate vaccine (PCV13) alone and four use the ten-valent PCV (PCV10) and PCV13. Vaccination uptake is greater than 90% in six sites and 67-78% in three sites. We measured the effects of introducing high-valency PCVs on the incidence of invasive pneumococcal disease in children younger than 5 years. Methods We compared the incidence of invasive pneumococcal disease in each of the 4 years after the introduction of PCV13 alone or PCV10 and PCV13 with the average incidence during the preceding period of heptavalent PCV (PCV7) use, overall and by serotype category. We calculated incidence rate ratios (IRRs) and 95% CIs for each year and pooled the values for all sites in a random effects meta-analysis. Findings 4 years after the introduction of PCV13 alone or PCV10 and PCV13, the pooled IRR was 0.53 (95% CI 0.43-0.65) for invasive pneumococcal disease in children younger than 5 years caused by any serotype, 0.16 (0.07-0.40) for disease caused by PCV7 serotypes, 0.17 (0.07-0.42) for disease caused by 1, 5, and 7F serotypes, and 0.41 (0.25-0.69) for that caused by 3, 6A and 19A serotypes. We saw a similar pattern when we restricted the analysis to sites where only PCV13 was used. The pooled IRR for invasive pneumococcal disease caused by non-PCV13 serotypes was 1.62 (1.09-2.42). Interpretation The incidence of invasive pneumococcal disease caused by all serotypes decreased due to a decline in the incidence of vaccine serotypes. By contrast, that of invasive pneumococcal disease caused by non-PCV13 serotypes increased, which suggests serotype replacement. Long-term surveillance will be crucial to monitor the further effects of PCV10 and PCV13 vaccination programmes in young children.
引用
收藏
页码:648 / 656
页数:9
相关论文
共 50 条
  • [1] Effect of pneumococcal conjugate vaccines on invasive pneumococcal disease Reply
    de Cunto Brandileone, Maria Cristina
    Castaneda-Orjuela, Carlos
    Grassi Almeida, Samanta Cristine
    Andrade, Ana Lucia
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (04): : 453 - 454
  • [2] Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SplDnet observational multicentre study
    Savulescu, Camelia
    Krizova, Pavla
    Valentiner-Branth, Palle
    Ladhani, Shamez
    Rinta-Kokko, Hanna
    Levy, Corinne
    Mereckiene, Jolita
    Knol, Mirjam
    Winje, Brita A.
    Ciruela, Pilar
    de Miguel, Sara
    Guevara, Marcela
    MacDonald, Laura
    Kozakova, Jana
    Slotved, Hans-Christian
    Fry, Norman K.
    Nuorti, J. Pekka
    Danis, Kostas
    Corcoran, Mary
    van der Ende, Arie
    Vestrheim, Didrik F.
    Munoz-Almagro, Carmen
    Sanz, Juan-Carlos
    Castilla, Jesus
    Smith, Andrew
    Colzani, Edoardo
    Celentano, Lucia Pastore
    Hanquet, Germaine
    [J]. VACCINE, 2022, 40 (29) : 3963 - 3974
  • [3] A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children
    Mungall, Bruce A.
    Hoet, Bernard
    Nieto Guevara, Javier
    Soumahoro, Lamine
    [J]. EXPERT REVIEW OF VACCINES, 2022, 21 (02) : 201 - 214
  • [4] Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
    Izurieta, Patricia
    Scherbakov, Michael
    Guevara, Javier Nieto
    Vetter, Volker
    Soumahoro, Lamine
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [5] Articles The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study
    Agudelo, Clara Ines
    Castaneda-Orjuela, Carlos
    de Cunto Brandileone, Maria Cristina
    Echaniz-Aviles, Gabriela
    Grassi Almeida, Samanta Cristine
    Carnalla-Barajas, Maria Noemi
    Regueira, Mabel
    Fossati, Sofia
    Alarcon, Pedro
    Araya, Pamela
    Duarte, Carolina
    Sanchez, Jacqueline
    Novas, Mirna
    Torano-Peraza, Gilda
    Rodriguez-Ortega, Misladys
    Chamorro-Cortesi, Gustavo
    Kawabata, Anibal
    Garcia-Gabarrot, Gabriela
    Camou, Teresa
    Spadola, Enza
    Payares, Daisy
    Andrade, Ana Lucia
    Di Fabio, Jose Luis
    Castaneda, Elizabeth
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (03): : 405 - 417
  • [6] Asthma and Invasive Pneumococcal Disease in the Age of Pneumococcal Conjugate Vaccines
    Tan, Tina Q.
    [J]. PEDIATRICS, 2020, 145 (01)
  • [7] Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children
    Von Kries, R
    Hermann, M
    Hachmeister, A
    Siedler, A
    Schmitt, HJ
    Al-Lahham, A
    Reinert, RR
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (11) : 1017 - 1023
  • [8] Response to letter to the editor on a systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children
    Mungall, Bruce A.
    Hoet, Bernard
    Guevara, Javier Nieto
    Soumahoro, Lamine
    [J]. EXPERT REVIEW OF VACCINES, 2022, 21 (12) : 1931 - 1931
  • [9] Letter to the editor in response to: A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children
    Feemster, Kristen
    Banniettis, Natalie
    Buchwald, Ulrike K.
    [J]. EXPERT REVIEW OF VACCINES, 2022, 21 (12) : 1929 - 1929
  • [10] State of the globe: Effect of pneumococcal conjugate vaccines on nonvaccine-type invasive pneumococcal disease
    Raina, Sunil Kumar
    [J]. JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2019, 11 (01) : 1 - 1